Skip to main content

Month: June 2020

Greenlane Launches Consumer-Facing Product Verification Program G-Verify Powered by Lucid Green

BOCA RATON, Fla., June 15, 2020 (GLOBE NEWSWIRE) — Greenlane Holdings, Inc. (“Greenlane” or “the Company”) (Nasdaq: GNLN), one of the largest global sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today unveiled G-Verify, a consumer-facing, scannable verification program that allows brands to communicate product information directly to consumers. Powered by Lucid Green’s Lucid ID platform, G-Verify can be used by brands to confirm product authenticity, share manufacturing certifications, child-resistant compliance details, reviews, dosage, and educational content through unique QR codes.G-Verify harnesses the power of Lucid Green’s 36,000 registered users and up to 600 daily scans per brand to provide reliable product, safety, and educational information directly to consumers...

Continue reading

Tauriga Sciences, Inc. Introduces Its Rainbow Deluxe Sampler Pack – Special Price: $99.99

The Rainbow Deluxe Sampler Pack will be Available Exclusively on the Company’s E-Commerce Website and is Comprised of One Blister Pack of Each Tauri-Gum™ FlavorPomegranate , Blood Orange , Peach-Lemon , Pear Bellini , Mint , Black Currant NEW YORK, NY, June 15, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (versions: infused with CBD, CBG, Vitamin C & Zinc) and edibles product(s) as well as two ongoing Biotechnology initiatives, today introduced its innovative and dynamic new product offering: The Rainbow Deluxe Sampler Pack (“Rainbow Pack”). The Rainbow Pack is comprised of one blister pack of each Tauri-Gum™ flavor (6 blister packs in total)...

Continue reading

Paper Slitting Machine Market to Reach USD 548.6 million by 2027; Need to Surge Production Capacity Will Favor Growth: Fortune Business Insights™

Pune, June 15, 2020 (GLOBE NEWSWIRE) — The global paper slitting machine market is anticipated to gain traction from the rising initiatives by several organizations to lower energy consumption of the paper slitting machine by surging production capacity and bringing in digitization. This information is given by Fortune Business Insights™ in a recently published report, titled, “Paper Slitting Machine Market Size, Share & Industry Analysis, By Blade Type (Razor Blade, Shear Blade, and Air Score Blade), By Technology (Manual, Semi-Automatic, and Fully Automatic) and Regional Forecast, 2020-2027.” The report further mentions that the paper slitting machine market size was USD 417.4 million in 2019 and is projected to reach USD 548.6 million by 2027, exhibiting a CAGR of 3.5% during the forecast period.We are taking continuous...

Continue reading

Wimsatt Building Materials Improves Distribution Efficiency with Descartes and Geotab

WATERLOO, Ontario, June 15, 2020 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq: DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Wayne, Michigan-based Wimsatt Building Materials, a Midwestern distributor of quality exterior building products, is using Descartes Route Planner™ On-demand and Geotab® GO™ devices to help make its distribution network in Michigan and Northern Ohio more efficient.“We now have the tools to automate formerly manual processes, which increases our efficiency in vehicle routing, asset tracking, fleet maintenance, Department of Transportation (DOT) compliance and more,” said Barry Crane, Director of Logistics at Wimsatt Building Materials. “Our Descartes/Geotab solution has allowed us to improve asset utilization, refine our processes, and increase...

Continue reading

New Look Vision Group Inc. Announces the Completion of  New Financing Arrangements

MONTRÉAL, June 15, 2020 (GLOBE NEWSWIRE) — New Look Vision Group Inc. (“New Look Vision” or the “Company”) (TSX: BCI) announced today the finalization of new financing arrangements for $40 million.With an initial investment in 2013, Fonds de solidarité FTQ (the “Fonds”) reaffirms its confidence in the Company by investing an additional $40 million. The credit facility granted to New Look vision is part of the Fonds’ plan to support Québec businesses during the COVID-19 pandemic.Antoine Amiel, President and Chief Executive Officer of New Look Vision, stated: “Our rapid response to the crisis was centered primarily on the safety and well-being of our employees, associates and clients.  This additional investment is part of the financial arrangements we made early in the crisis to ensure our financial...

Continue reading

Groupe Vision New Look inc. annonce la finalisation des nouveaux arrangements financiers de 40$ million

MONTRÉAL, 15 juin 2020 (GLOBE NEWSWIRE) — Groupe Vision New Look Inc. (« Vision New Look » ou la « société ») (TSX : BCI) a annoncé aujourd’hui la finalisation d’une facilité de crédit non garantie d’un montant de 40 millions $.Antoine Amiel, président et chef de la direction de Vision New Look, a déclaré : « Notre réaction rapide à la crise a été basée avant tout sur la sécurité et le bien-être de nos employés, associés et clients.  Cet investissement supplémentaire s’inscrit dans le cadre des arrangements financiers que nous avons pris au début de la crise pour assurer notre autonomie financière et notre capacité à reprendre la croissance externe le plus tôt possible. »Ayant investi une première fois en 2013, le Fonds de solidarité FTQ réitère sa confiance dans la société en y réinvestissant 40 millions $.  La facilité de crédit...

Continue reading

Radisson Announces Upsize of its previously announced Private Placement to $2.4 Million

Not for distribution to United States newswire services or for dissemination in the United StatesROUYN-NORANDA, Quebec, June 15, 2020 (GLOBE NEWSWIRE) — Radisson Mining Resources Inc. (TSX-V: RDS, OTC: RMRDF) (“Radisson” or the “Company“) is pleased to announce that due to demand from current shareholders, the Company is upsizing the recently announced non-brokered private placement offering (See Radisson announces investment by the Marshall Precious Metals Fund managed by David Garofalo), and expects to raise at least CAD$2,400,000 (the “Offering”). This private placement will consist of a combination (to be decided by the Company) of: (i) common class A shares (the “Class A shares”) priced at CAD$0.20 and (ii) charity flow-through shares (the “Québec Charity FT Shares”) priced at CAD$0.362. The Company is reserving the right...

Continue reading

Radisson annonce l’augmentation de son placement privé préalablement annoncé jusqu’à 2,4 millions $

Le présent communiqué ne doit pas être distribué aux agences de diffusion de communiqués de presse des États-Unis ni diffusé aux États-UnisROUYN-NORANDA, Québec, 15 juin 2020 (GLOBE NEWSWIRE) — Ressources minières Radisson Inc. (TSX-V : RDS, OTC : RMRDF) (« Radisson » ou la « Société ») est heureuse d’annoncer que dû à l’intérêt d’actionnaires actuels elle augmente le placement privé sans l’entremise de courtier préalablement annoncé (Voir Radisson annonce un investissement du Fond Marshall Precious Metals dirigé par David Garofalo) pour une valeur globale d’au moins 2 400 000 $ (le « placement »). Le placement consiste en une combinaison : (i) d’actions ordinaires de catégorie A de la Société (les « actions ordinaires ») à un prix de 0,20 $ par action ordinaire et (ii) d’actions accréditives de Charité du Québec de catégorie A...

Continue reading

Brickell Biotech Announces Positive Phase 3 Pivotal Study Results for Sofpironium Bromide in Japan Released by Development Partner, Kaken Pharmaceutical

Data based on registration study in Japan of sofpironium bromide gel, 5% in patients with primary axillary hyperhidrosisAll primary and secondary endpoints were met and achieved statistical significanceBOULDER, Colo., June 15, 2020 (GLOBE NEWSWIRE) — Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced the release of positive Phase 3 pivotal study results from its development partner, Kaken Pharmaceutical Co. Ltd., in Japan. All primary and secondary efficacy endpoints of the study were met. The results were presented as part of the Late-Breaking Research Program during the American Academy of Dermatology (AAD) Virtual Meeting Experience. The presentation...

Continue reading

CENTOGENE Reports First-Quarter 2020 Financial Results and Corporate Progress

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 15, 2020 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, today provided an update on its corporate progress and reported its financial results for the three months ended March 31, 2020.€12.1 million in revenues, an increase of 13% compared to three months ended March 31, 2019Continued expansion of global proprietary rare disease platform with approximately 3.0 billion weighted data points from over 530,000 patients representing 120 different countries as of March 31, 2020Over 60 biomarker programs, with over 25 biomarker programs (covering more than 22 diseases) having completed the first...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.